Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.
Crowdfund Insider1h
Industry Laments $LIBRA Fiasco
The recent $LIBRA memecoin debacle is the latest in a long list of lessons in how the cryptocurrency industry needs to shape ...
johnmenadue.com5h
Environment: Australia’s exported greenhouse gas emissions are double our domestic emissions
Australia is the fourth largest exporter of fossil fuel emissions. There’s never been a global transition from one energy ...
The Block Island Times9h
PART 10 INVISIBLE FORCES
Genesis 2:16-17 And the Lord God commanded the man, saying, Of every tree of the garden thou mayest freely eat: But of the ...
Ethiopian16h
Investigation: shedding light on the convoluted CCECC, Somali water project scandal
In a letter addressed to The Reporter on February 13, 2025, CCECC and its attorneys stated the coverage was untrue and claimed the contractor only signed on to the second phase of the Jigjiga Water ...
A week in the life of Merseyrail's troubled new trains
It's fair to say that Merseyrail's new fleet of trains have had a tricky start to life. It was all the way back in 2016 when ...
Magnetic Media21h
Ministry of Education Announces Education Week 2025 Schedule
PRESS RELEASE FROM THE MINISTRY OF EDUCATION Providenciales, Turks and Caicos Islands – Friday, 21025: Education Week 2025 ...